Summary

This study conducted four primary actions to ascertain the Medical Robots Market present size. Data regarding the market, its parent market, and its peer markets were gathered through an extensive study that was carried out utilizing secondary research techniques. In order to validate these findings, hypotheses, and sizing with industry experts across the value chain, primary research had to be done. To determine the total market size, a mix of top-down and bottom-up techniques was employed. Next, data triangulation techniques and market breakdown were used to estimate the market sizes of segments and subsegments.

During the primary research phase, a comprehensive approach was adopted, involving interviews with a diverse array of sources from both the supply and demand sides. These interviews aimed to gather qualitative and quantitative data essential for compiling this report. Primary sources primarily comprised industry experts spanning core and related sectors, as well as favored suppliers, manufacturers, distributors, service providers, technology innovators, and entities associated with all facets of this industry's value chain. In-depth interviews were meticulously conducted with a range of primary respondents, including key industry stakeholders, subject-matter authorities, C-level executives representing pivotal market players, and industry advisors. The objective was to obtain and authenticate critical qualitative and quantitative insights and to evaluate future potentialities comprehensively.
Medical Robots Market based on Product Type:
• Surgical Robotic Systems
• Rehabilitative Robotic Systems
• Non-invasive Radiosurgery Robots
• Hospital and Pharmacy Robotic Systems
• Other Robotic Systems
Medical Robots Market based on Geography:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
Worldwide, hospital readmissions are primarily caused by medication errors and dispensing problems. Medication errors, as defined by the National Coordinating Council for Medication Error Reporting and Prevention, are any preventable incidents that may lead to inappropriate medication use or patient injury while the medication is being administered under the supervision of a healthcare provider, patient, or consumer. Medication errors can be caused by a number of major factors, including inadequate order communication between doctors and pharmacists, misinterpretations of similar labels and prescriptions during drug preparation, administration, or dispensing, and unsafe pharmacy storage practices.

Automated pharmacy systems are seen to be among the best ways to lessen these mistakes. The number of medication errors and dispensing errors in hospitals significantly decreased the last time automated dispensing machines (ADMs) and automated dispensing cabinets (ADCs) were successfully used. Therefore, governments in a number of nations are encouraging the use of automated dispensing and pharmaceutical equipment in pharmacies and hospitals in an effort to reduce drug and dispensing errors. The use of pharmacy automation technologies has increased as a result of this.

When compared to less invasive procedures, the use of robotic-assisted surgeries is typically more expensive. The American Congress of Obstetricians and Gynecologists recommends saving robotic hysterectomy for uncommon and difficult situations. In the US, hysterectomies may cost up to USD 960 million more year if robotic surgery were used for all of them. Mantra, a robotic surgical system from SS Innovations (India), costs about Rs 4.5 crore. The da Vinci system, a popular robotic platform, costs between USD 1.5 million and USD 2.5 million (about Rs 15 crore). As a result, the rising costs related to robotic surgery are expected to hinder the market expansion for medical robots.
Growing economies in emerging regions offer profitable opportunities for companies in the medical robotics industry, mainly due to the growing use of surgical robots in a variety of procedures. Emerging nations have seen a significant increase in surgical procedures over the last ten years, driven by a growing patient population and a rise in medical tourism. Remarkably, countries such as Brazil, Russia, India, China, and South Africa have become some of the fastest-growing economies globally and are expected to account for one-third of all healthcare spending worldwide by 2022, according to the World Economic Forum.

Compared to industrialized equivalents, emerging economies such as India provide radiation treatments at significantly lower costs. For example, according to data from Tour2India 4Health Group, CyberKnife procedures can cost anywhere from USD 50,000 to $100,000 in the US, but about 60-80% less in India. Furthermore, the regulatory environment is typically less onerous and requires less data in underdeveloped countries. Market participants embrace regulatory rules because they are seen as more flexible and business-friendly, especially in the Asia-Pacific area.

Thus, the increasing trend in healthcare expenditure and surgical procedures, along with the deliberate forays of prominent industry participants into developing economies, herald substantial prospects for the medical robotics domain.

Prominent players in medical robots market include Intuitive Surgical, Inc. (US), Stryker Corporation (US), Medtronic Plc (US), Becton, Dickinson And Company (US), Omnicell, Inc. (US), Arxium (Canada), Asensus Surgical, Inc.(US), Zap Surgical Systems, Inc.(US), Renishaw Plc (UK), Smith & Nephew Plc (UK), Zimmer Biomet Holdings, Inc. (US), DIH Holdings US Inc. (US), Accuray Incorporated (US), CMR Surgical (UK), Ekso Bionics Holdings, Inc. (US), Bionik Laboratories Corp. (US), Lifeward, Inc. (Israel), Cyberdyne Inc.(Japan), Avateramedical Gmbh.(Germany),Johnson & Johnson (US), Swisslog Healthcare (Switzerland), Relay Robotics (US), Aethon (US), Xenex Disinfection Services Inc. (US), and Zoll Medical Corporation (US).


• This report illustrates the most vital attributes of the Medical Robots Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Medical Robots Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Medical Robots Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Medical Robots Market.

ページTOPに戻る

Table of Contents

Table of Contents
1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Product Type: Market Size & Analysis
5.1. Overview
5.2. Surgical Robotic Systems
5.3. Rehabilitative Robotic Systems
5.4. Non-invasive Radiosurgery Robots
5.5. Hospital and Pharmacy Robotic Systems
5.6. Other Robotic Systems
6. Geography: Market Size & Analysis
6.1. Overview
6.2. North America (U.S., Mexico, Canada)
6.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
6.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
6.5. Latin America (Brazil, Argentina)
6.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
7. Competitive Landscape
7.1. Competitor Comparison Analysis
7.2. Market Developments
7.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
7.2.2. Product Launches and execution
8. Vendor Profiles
8.1. IROBOT CORPORATION (U.S.)
8.1.1. Overview
8.1.2. Financial Overview
8.1.3. Product Offerings
8.1.4. Developments
8.1.5. Business Strategy
8.2. TITAN MEDICAL INC. (CANADA)
8.2.1. Overview
8.2.2. Financial Overview
8.2.3. Product Offerings
8.2.4. Developments
8.2.5. Business Strategy
8.3. HANSEN TECHNOLOGIES (AUSTRALIA)
8.3.1. Overview
8.3.2. Financial Overview
8.3.3. Product Offerings
8.3.4. Developments
8.3.5. Business Strategy
8.4. RENISHAW PLC (U.K.)
8.4.1. Overview
8.4.2. Financial Overview
8.4.3. Product Offerings
8.4.4. Developments
8.4.5. Business Strategy
8.5. INTUITIVE SURGICAL (U.S.)
8.5.1. Overview
8.5.2. Financial Overview
8.5.3. Product Offerings
8.5.4. Developments
8.5.5. Business Strategy
8.6. MEDTRONIC (IRELAND)
8.6.1. Overview
8.6.2. Financial Overview
8.6.3. Product Offerings
8.6.4. Developments
8.6.5. Business Strategy
8.7. ACCURAY INCORPORATED (U.S.)
8.7.1. Overview
8.7.2. Financial Overview
8.7.3. Product Offerings
8.7.4. Developments
8.7.5. Business Strategy
8.8. STRYKER (U.S.)
8.8.1. Overview
8.8.2. Financial Overview
8.8.3. Product Offerings
8.8.4. Developments
8.8.5. Business Strategy
8.9. VARIAN MEDICAL SYSTEMS, INC. (U.K.)
8.9.1. Overview
8.9.2. Financial Overview
8.9.3. Product Offerings
8.9.4. Developments
8.9.5. Business Strategy
8.10. STEREOTAXIS, INC. (U.S.)
8.10.1. Overview
8.10.2. Financial Overview
8.10.3. Product Offerings
8.10.4. Developments
8.10.5. Business Strategy

9. Analyst Opinion
10. Annexure
10.1. Report Scope
10.2. Market Definitions
10.3. Research Methodology
10.3.1. Data Collation and In-house Estimation
10.3.2. Market Triangulation
10.3.3. Forecasting
10.4. Report Assumptions
10.5. Declarations
10.6. Stakeholders
10.7. Abbreviations

ページTOPに戻る

List of Tables/Graphs

Tables
TABLE 1. MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 2. MEDICAL ROBOTS MARKET VALUE FOR SURGICAL ROBOTIC SYSTEMS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 3. MEDICAL ROBOTS MARKET VALUE FOR REHABILITATIVE ROBOTIC SYSTEMS, BY TAVR (TRANSCATHETER AORTIC VALVE REPLACEMENT), 2021-2030 (USD BILLION)
TABLE 4. MEDICAL ROBOTS MARKET VALUE FOR NON-INVASIVE RADIOSURGERY ROBOTS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 5. MEDICAL ROBOTS MARKET VALUE FOR HOSPITAL AND PHARMACY ROBOTIC SYSTEMS, BY GEOGRAPHY, 2021-2030 (USD BILLION)
TABLE 6. NORTH AMERICA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 7. NORTH AMERICA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 8. U.S MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 9. CANADA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 10. MEXICO MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 11. EUROPE MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 12. GERMANY MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 13. U.K MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 14. FRANCE MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 15. ITALY MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 16. SPAIN MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 17. ROE MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 18. ASIA PACIFIC MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 19. CHINA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 20. INDIA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 21. JAPAN MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 22. JAPAN MEDICAL ROBOTS MARKET VALUE, BY RESOLUTION, 2021-2030 (USD BILLION)
TABLE 23. JAPAN MEDICAL ROBOTS MARKET VALUE, BY CAMERA TYPE, 2021-2030 (USD BILLION)
TABLE 24. REST OF APAC MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 25. LATIN AMERICA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 26. BRAZIL MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 27. ARGENTINA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 28. MIDDLE EAST AND AFRICA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 29. SAUDI ARABIA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 30. UAE MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 31. REST OF MIDDLE EAST AND AFRICA MEDICAL ROBOTS MARKET VALUE, BY PRODUCT TYPE, 2021-2030 (USD BILLION)
TABLE 32. IROBOT CORPORATION (U.S.): FINANCIALS
TABLE 33. IROBOT CORPORATION (U.S.): PRODUCTS & SERVICES
TABLE 34. IROBOT CORPORATION (U.S.): RECENT DEVELOPMENTS
TABLE 35. TITAN MEDICAL INC. (CANADA): FINANCIALS
TABLE 36. TITAN MEDICAL INC. (CANADA): PRODUCTS & SERVICES
TABLE 37. TITAN MEDICAL INC. (CANADA): RECENT DEVELOPMENTS
TABLE 38. HANSEN TECHNOLOGIES (AUSTRALIA): FINANCIALS
TABLE 39. HANSEN TECHNOLOGIES (AUSTRALIA): PRODUCTS & SERVICES
TABLE 40. HANSEN TECHNOLOGIES (AUSTRALIA): RECENT DEVELOPMENTS
TABLE 41. RENISHAW PLC (U.K.): FINANCIALS
TABLE 42. RENISHAW PLC (U.K.): PRODUCTS & SERVICES
TABLE 43. RENISHAW PLC (U.K.): RECENT DEVELOPMENTS
TABLE 44. INTUITIVE SURGICAL (U.S.): FINANCIALS
TABLE 45. INTUITIVE SURGICAL (U.S.): PRODUCTS & SERVICES
TABLE 46. INTUITIVE SURGICAL (U.S.): RECENT DEVELOPMENTS
TABLE 47. MEDTRONIC (IRELAND): FINANCIALS
TABLE 48. MEDTRONIC (IRELAND): PRODUCTS & SERVICES
TABLE 49. MEDTRONIC (IRELAND): RECENT DEVELOPMENTS
TABLE 50. ACCURAY INCORPORATED (U.S.): FINANCIALS
TABLE 51. ACCURAY INCORPORATED (U.S.): PRODUCTS & SERVICES
TABLE 52. ACCURAY INCORPORATED (U.S.): DEVELOPMENTS
TABLE 53. STRYKER (U.S.): FINANCIALS
TABLE 54. STRYKER (U.S.): PRODUCTS & SERVICES
TABLE 55. STRYKER (U.S.): RECENT DEVELOPMENTS
TABLE 56. VARIAN MEDICAL SYSTEMS, INC. (U.K.): FINANCIALS
TABLE 57. VARIAN MEDICAL SYSTEMS, INC. (U.K.): PRODUCTS & SERVICES
TABLE 58. VARIAN MEDICAL SYSTEMS, INC. (U.K.): RECENT DEVELOPMENTS
TABLE 59. STEREOTAXIS, INC. (U.S.): FINANCIALS
TABLE 60. STEREOTAXIS, INC. (U.S.): PRODUCTS & SERVICES
TABLE 61. STEREOTAXIS, INC. (U.S.): RECENT DEVELOPMENTS